Cargando…
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
We recently reported that brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) binds Prohibitin 2 (PHB2) in cytoplasm, thereby causing a loss of function of the PHB2 tumor suppressor in the nuclei of breast cancer cells. However, little is known regarding the mechanism by which BIG3 in...
Autores principales: | Kim, Nam-Hee, Yoshimaru, Tetsuro, Chen, Yi-An, Matsuo, Taisuke, Komatsu, Masato, Miyoshi, Yasuo, Tanaka, Eiji, Sasa, Mitsunori, Mizuguchi, Kenji, Katagiri, Toyomasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460025/ https://www.ncbi.nlm.nih.gov/pubmed/26052702 http://dx.doi.org/10.1371/journal.pone.0127707 |
Ejemplares similares
-
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
por: Yoshimaru, Tetsuro, et al.
Publicado: (2015) -
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
por: Yoshimaru, Tetsuro, et al.
Publicado: (2014) -
Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2013) -
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017) -
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017)